Pioglitazone Hydrochloride
- Product NDC
- 63629-3330
- 11-digit product format
- 636293330
- Labeler code
- 63629
- Product ID
- 63629-3330_66717657-3760-463a-be2c-af6be7ed4e16
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA200044
- Marketing category
- ANDA
- Marketing start
- 2013-02-13
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63629-3330-1 | 2022-02-16 | C162847 | 48780-1 | 9d75b9d0-ee03-f424-e053-dadaa90a57ce | 66717657-3760-463a-be2c-af6be7ed4e16 |
| 63629-3330-2 | 2022-02-16 | C162847 | 48780-1 | 9d75b9d0-ee03-f424-e053-dadaa90a57ce | 66717657-3760-463a-be2c-af6be7ed4e16 |
| 63629-3330-3 | 2022-02-16 | C162847 | 48780-1 | 9d75b9d0-ee03-f424-e053-dadaa90a57ce | 66717657-3760-463a-be2c-af6be7ed4e16 |
| 63629-3330-4 | 2022-02-16 | C162847 | 48780-1 | 9d75b9d0-ee03-f424-e053-dadaa90a57ce | 66717657-3760-463a-be2c-af6be7ed4e16 |
| 63629-3330-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ee03-f424-e053-dadaa90a57ce | 66717657-3760-463a-be2c-af6be7ed4e16 |
| 63629-3330-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ee03-f424-e053-dadaa90a57ce | 66717657-3760-463a-be2c-af6be7ed4e16 |
| 63629-3330-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ee03-f424-e053-dadaa90a57ce | 66717657-3760-463a-be2c-af6be7ed4e16 |
| 63629-3330-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ee03-f424-e053-dadaa90a57ce | 66717657-3760-463a-be2c-af6be7ed4e16 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PIOGLITAZONE HYDROCHLORIDE | ACTIVE INGREDIENT | JQT35NPK6C | PIOGLITAZONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| PIOGLITAZONE | ACTIVE MOIETY | X4OV71U42S | PIOGLITAZONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| HYDROXYPROPYL CELLULOSE (TYPE E) | INACTIVE INGREDIENT | 66O7AQV0RT | PIOGLITAZONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | PIOGLITAZONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | PIOGLITAZONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-3330 | PIOGLITAZONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1010 | Legacy NDC | 20241109_66717657-3760-463a-be2c-af6be7ed4e16.zip |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63629-3330-1 | 63629333001 | 30 TABLET in 1 BOTTLE (63629-3330-1) | 30 tablet | 2014-04-28 | 0000-00-00 | No | No | Current |
| 63629-3330-2 | 63629333002 | 90 TABLET in 1 BOTTLE (63629-3330-2) | 90 tablet | 2014-04-28 | 0000-00-00 | No | No | Current |
| 63629-3330-3 | 63629333003 | 60 TABLET in 1 BOTTLE (63629-3330-3) | 60 tablet | 2014-06-26 | 0000-00-00 | No | No | Current |
| 63629-3330-4 | 63629333004 | 120 TABLET in 1 BOTTLE (63629-3330-4) | 120 tablet | 2022-02-08 | 0000-00-00 | No | No | Current |